Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Interventional × Vigabatrin × Clear all

Phase

Status

Unknown 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 1 Seizures 1

Interventions

Cyclophosphamide 386 Carboplatin 336 Gemcitabine 327 pembrolizumab 322 Cisplatin 322 Paclitaxel 291 Radiotherapy 290 Docetaxel 282 Bevacizumab 246 Rituximab 232 Capecitabine 220 Nivolumab 213 Dexamethasone 201 Fluorouracil 187 fludarabine 175 Oxaliplatin 175 Doxorubicin 152 Pemetrexed 148 Irinotecan 147 Etoposide 142 Leucovorin 141 Cytarabine 131 Bortezomib 128 fludarabine phosphate 126 Cetuximab 123 Lenalidomide 122 Filgrastim 119 Erlotinib Hydrochloride 119 Temozolomide 111 Trastuzumab 108

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01266291 2017-07-12

STARS

University of Pennsylvania

Phase 4 Terminated

1 enrolled 8 charts

Seizures, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡